Literature DB >> 33428030

Ex vivo Bone Models and Their Potential in Preclinical Evaluation.

E E A Cramer1, K Ito1, S Hofmann2.   

Abstract

PURPOSE OF REVIEW: Novel therapies for damaged and diseased bone are being developed in a preclinical testing process consisting of in vitro cell experiments followed by in vivo animal studies. The in vitro results are often not representative of the results observed in vivo. This could be caused by the complexity of the natural bone environment that is missing in vitro. Ex vivo bone explant cultures provide a model in which cells are preserved in their native three-dimensional environment. Herein, it is aimed to review the current status of bone explant culture models in relation to their potential in complementing the preclinical evaluation process with specific attention paid to the incorporation of mechanical loading within ex vivo culture systems. RECENT
FINDINGS: Bone explant cultures are often performed with physiologically less relevant bone, immature bone, and explants derived from rodents, which complicates translatability into clinical practice. Mature bone explants encounter difficulties with maintaining viability, especially in static culture. The integration of mechanical stimuli was able to extend the lifespan of explants and to induce new bone formation. Bone explant cultures provide unique platforms for bone research and mechanical loading was demonstrated to be an important component in achieving osteogenesis ex vivo. However, more research is needed to establish a representative, reliable, and reproducible bone explant culture system that includes both components of bone remodeling, i.e., formation and resorption, in order to bridge the gap between in vitro and in vivo research in preclinical testing.

Entities:  

Keywords:  Bone explants; Bone formation; Bone resorption; Ex vivo bone model; Mechanical loading; Osteocytes

Mesh:

Year:  2021        PMID: 33428030      PMCID: PMC7935733          DOI: 10.1007/s11914-020-00649-5

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  138 in total

1.  The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation.

Authors:  Yan Liu; Ramesh A Bhat; Laura M Seestaller-Wehr; Shoichi Fukayama; Annamarie Mangine; Robert A Moran; Barry S Komm; Peter V N Bodine; Julia Billiard
Journal:  Mol Endocrinol       Date:  2006-11-09

Review 2.  Normal bone anatomy and physiology.

Authors:  Bart Clarke
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

3.  Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli.

Authors:  Nobuaki Ito; Asiri R Wijenayaka; Matthew Prideaux; Masakazu Kogawa; Renee T Ormsby; Andreas Evdokiou; Lynda F Bonewald; David M Findlay; Gerald J Atkins
Journal:  Mol Cell Endocrinol       Date:  2014-10-16       Impact factor: 4.102

4.  Combined exposure to big endothelin-1 and mechanical loading in bovine sternal cores promotes osteogenesis.

Authors:  Luisa A Meyer; Michael G Johnson; Diane M Cullen; Juan F Vivanco; Robert D Blank; Heidi-Lynn Ploeg; Everett L Smith
Journal:  Bone       Date:  2016-02-12       Impact factor: 4.398

5.  Intermittent compressive load stimulates osteogenesis and improves osteocyte viability in bones cultured "in vitro".

Authors:  E Lozupone; C Palumbo; A Favia; M Ferretti; S Palazzini; F P Cantatore
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

6.  Alginate-nanohydroxyapatite hydrogel system: Optimizing the formulation for enhanced bone regeneration.

Authors:  J Barros; M P Ferraz; J Azeredo; M H Fernandes; P S Gomes; F J Monteiro
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-07-21       Impact factor: 7.328

7.  Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.

Authors:  Feng Li; Jarrett D Cain; Joyce Tombran-Tink; Christopher Niyibizi
Journal:  J Bone Miner Metab       Date:  2019-01-03       Impact factor: 2.626

8.  Interleukin-1-induced acute bone resorption facilitates the secretion of fibroblast growth factor 23 into the circulation.

Authors:  Miwa Yamazaki; Masanobu Kawai; Kazuaki Miyagawa; Yasuhisa Ohata; Kanako Tachikawa; Saori Kinoshita; Jin Nishino; Keiichi Ozono; Toshimi Michigami
Journal:  J Bone Miner Metab       Date:  2014-07-05       Impact factor: 2.626

9.  Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.

Authors:  Derek F Amanatullah; John S Tamaresis; Pauline Chu; Michael H Bachmann; Nhat M Hoang; Deborah Collyar; Aaron T Mayer; Robert B West; William J Maloney; Christopher H Contag; Bonnie L King
Journal:  Breast Cancer Res       Date:  2017-11-15       Impact factor: 6.466

10.  Extracellular S100A4 negatively regulates osteoblast function by activating the NF-κB pathway.

Authors:  Haemin Kim; Yong Deok Lee; Min Kyung Kim; Jun-Oh Kwon; Min-Kyoung Song; Zang Hee Lee; Hong-Hee Kim
Journal:  BMB Rep       Date:  2017-02       Impact factor: 4.778

View more
  1 in total

1.  The Embryonic Chick Femur Organotypic Model as a Tool to Analyze the Angiotensin II Axis on Bone Tissue.

Authors:  Thais Francini Garbieri; Victor Martin; Carlos Ferreira Santos; Pedro de Sousa Gomes; Maria Helena Fernandes
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.